HEADER HYDROLASE 06-OCT-23 8UGT TITLE E. ELIGENS BETA-GLUCURONIDASE BOUND TO UNC10206581-G COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-GLUCURONIDASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.31; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACHNOSPIRA ELIGENS; SOURCE 3 ORGANISM_TAXID: 39485; SOURCE 4 GENE: UIDA, ERS852490_00568, ERS852492_02599; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS BETA-GLUCURONIDASE, INHIBITOR, GLUCURONIDE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.B.SIMPSON,M.R.REDINBO REVDAT 2 11-SEP-24 8UGT 1 JRNL REVDAT 1 24-JUL-24 8UGT 0 JRNL AUTH A.L.GRABOSKI,J.B.SIMPSON,S.J.PELLOCK,N.MEHTA,B.C.CREEKMORE, JRNL AUTH 2 Y.ARIYARATHNA,A.P.BHATT,P.B.JARIWALA,J.J.SEKELA, JRNL AUTH 3 M.E.KOWALEWSKI,N.K.BARKER,A.L.MORDANT,V.B.BORLANDELLI, JRNL AUTH 4 H.OVERKLEEFT,L.E.HERRING,J.JIN,L.I JAMES,M.R.REDINBO JRNL TITL ADVANCED PIPERAZINE-CONTAINING INHIBITORS TARGET MICROBIAL JRNL TITL 2 BETA-GLUCURONIDASES LINKED TO GUT TOXICITY. JRNL REF RSC CHEM BIOL V. 5 853 2024 JRNL REFN ESSN 2633-0679 JRNL PMID 39211470 JRNL DOI 10.1039/D4CB00058G REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 37255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.370 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.9800 - 6.3800 1.00 2736 155 0.2182 0.2253 REMARK 3 2 6.3800 - 5.0700 1.00 2593 147 0.2254 0.2736 REMARK 3 3 5.0700 - 4.4300 1.00 2552 145 0.1981 0.2408 REMARK 3 4 4.4300 - 4.0200 1.00 2525 143 0.2065 0.2294 REMARK 3 5 4.0200 - 3.7300 1.00 2507 142 0.2142 0.2394 REMARK 3 6 3.7300 - 3.5100 1.00 2520 144 0.2472 0.2847 REMARK 3 7 3.5100 - 3.3400 1.00 2473 140 0.2590 0.2757 REMARK 3 8 3.3400 - 3.1900 1.00 2505 142 0.2731 0.3363 REMARK 3 9 3.1900 - 3.0700 1.00 2482 141 0.2898 0.3165 REMARK 3 10 3.0700 - 2.9600 1.00 2492 141 0.2958 0.3178 REMARK 3 11 2.9600 - 2.8700 1.00 2464 140 0.2988 0.2962 REMARK 3 12 2.8700 - 2.7900 1.00 2486 141 0.3167 0.3602 REMARK 3 13 2.7900 - 2.7200 1.00 2463 140 0.3293 0.3395 REMARK 3 14 2.7200 - 2.6500 1.00 2457 139 0.3641 0.4059 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.402 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.581 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 64.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4777 REMARK 3 ANGLE : 1.252 6500 REMARK 3 CHIRALITY : 0.073 692 REMARK 3 PLANARITY : 0.006 835 REMARK 3 DIHEDRAL : 18.018 1698 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8UGT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000277848. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37256 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 44.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.03524 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51270 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.360 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.075 M HEPES, PH 7.5, 15 % (W/V) PEG REMARK 280 1000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+1/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.26400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 88.52800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 44.26400 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 88.52800 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.26400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 88.52800 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 44.26400 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 88.52800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18210 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 72070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 89.96900 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -155.83088 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 -44.26400 REMARK 350 BIOMT1 4 0.500000 0.866025 0.000000 89.96900 REMARK 350 BIOMT2 4 0.866025 -0.500000 0.000000 -155.83088 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 -44.26400 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ASN A 148 REMARK 465 MET A 149 REMARK 465 MET A 150 REMARK 465 SER A 151 REMARK 465 GLY A 152 REMARK 465 MET A 153 REMARK 465 MET A 154 REMARK 465 GLY A 155 REMARK 465 GLY A 156 REMARK 465 MET A 157 REMARK 465 GLY A 158 REMARK 465 ALA A 159 REMARK 465 GLY A 160 REMARK 465 ALA A 161 REMARK 465 SER A 162 REMARK 465 ASP A 163 REMARK 465 LYS A 164 REMARK 465 LYS A 222 REMARK 465 ASP A 223 REMARK 465 TYR A 224 REMARK 465 ASN A 225 REMARK 465 ASN A 226 REMARK 465 GLY A 375 REMARK 465 GLY A 376 REMARK 465 GLY A 377 REMARK 465 ALA A 378 REMARK 465 ASN A 379 REMARK 465 PHE A 380 REMARK 465 GLY A 381 REMARK 465 GLY A 382 REMARK 465 THR A 610 REMARK 465 LYS A 611 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 32 CG CD CE NZ REMARK 470 THR A 43 OG1 CG2 REMARK 470 GLU A 76 CG CD OE1 OE2 REMARK 470 VAL A 78 CG1 CG2 REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 LYS A 146 CG CD CE NZ REMARK 470 GLN A 166 CG CD OE1 NE2 REMARK 470 LYS A 206 CG CD CE NZ REMARK 470 GLU A 207 CG CD OE1 OE2 REMARK 470 GLU A 208 CG CD OE1 OE2 REMARK 470 LEU A 213 CG CD1 CD2 REMARK 470 TYR A 215 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 216 CG OD1 ND2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 ILE A 227 CG1 CG2 CD1 REMARK 470 LYS A 230 CG CD CE NZ REMARK 470 LYS A 240 CG CD CE NZ REMARK 470 LEU A 241 CG CD1 CD2 REMARK 470 GLU A 243 CG CD OE1 OE2 REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 GLU A 248 CG CD OE1 OE2 REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 ILE A 253 CG1 CG2 CD1 REMARK 470 ARG A 257 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 270 CG CD CE NZ REMARK 470 GLU A 383 CG CD OE1 OE2 REMARK 470 ARG A 384 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 391 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 30 -72.63 -41.04 REMARK 500 LYS A 32 75.61 -103.43 REMARK 500 MET A 44 110.74 -160.53 REMARK 500 ALA A 48 149.99 177.61 REMARK 500 SER A 73 115.68 -163.83 REMARK 500 TYR A 77 9.07 -60.23 REMARK 500 ALA A 89 119.01 -176.37 REMARK 500 HIS A 92 -123.51 83.37 REMARK 500 LEU A 121 96.60 -69.94 REMARK 500 ASN A 170 38.64 -92.21 REMARK 500 ASP A 172 42.21 -94.62 REMARK 500 ASP A 203 75.38 -110.86 REMARK 500 GLU A 208 72.27 -117.79 REMARK 500 PRO A 209 141.18 -38.17 REMARK 500 ASN A 216 82.89 -165.32 REMARK 500 LEU A 241 -11.71 -149.26 REMARK 500 SER A 247 2.71 -68.57 REMARK 500 GLU A 248 36.23 -157.27 REMARK 500 ASN A 263 56.01 -156.12 REMARK 500 ASN A 297 54.11 39.74 REMARK 500 ASN A 320 80.22 -152.79 REMARK 500 HIS A 335 33.25 75.42 REMARK 500 THR A 341 81.15 -60.67 REMARK 500 TYR A 344 149.81 177.22 REMARK 500 ASN A 371 111.09 -172.00 REMARK 500 TRP A 484 -99.67 -123.94 REMARK 500 TYR A 533 -5.89 91.53 REMARK 500 REMARK 500 REMARK: NULL DBREF1 8UGT A 1 611 UNP A0A174ZZA3_9FIRM DBREF2 8UGT A A0A174ZZA3 1 611 SEQADV 8UGT SER A -2 UNP A0A174ZZA EXPRESSION TAG SEQADV 8UGT ASN A -1 UNP A0A174ZZA EXPRESSION TAG SEQADV 8UGT ALA A 0 UNP A0A174ZZA EXPRESSION TAG SEQADV 8UGT ASP A 120 UNP A0A174ZZA HIS 120 CONFLICT SEQRES 1 A 614 SER ASN ALA MET LEU TYR PRO VAL LEU THR GLN SER ARG SEQRES 2 A 614 LEU LEU SER ASP LEU SER GLY VAL TRP ASN PHE LYS LEU SEQRES 3 A 614 ASP ASN GLY LYS GLY PHE GLU GLU LYS TRP TYR GLU LYS SEQRES 4 A 614 PRO LEU LYS ASP ALA ASP THR MET PRO VAL PRO ALA SER SEQRES 5 A 614 TYR ASN ASP LEU LYS GLU GLY THR ASP PHE ARG ASP HIS SEQRES 6 A 614 TYR GLY TRP VAL PHE TYR GLN ARG ASN ILE SER VAL PRO SEQRES 7 A 614 GLU TYR VAL LYS SER GLN ARG ILE VAL LEU ARG CYS ALA SEQRES 8 A 614 ALA VAL THR HIS TYR ALA MET ILE TYR LEU ASN GLY LYS SEQRES 9 A 614 LEU ILE CYS GLU HIS LYS GLY GLY PHE LEU PRO PHE GLU SEQRES 10 A 614 VAL GLU LEU ASN ASP ASP LEU GLN ASP GLY ASP ASN LEU SEQRES 11 A 614 LEU THR ILE ALA VAL ASN ASN VAL ILE ASP TYR THR THR SEQRES 12 A 614 LEU PRO VAL GLY GLY LYS ALA ASN MET MET SER GLY MET SEQRES 13 A 614 MET GLY GLY MET GLY ALA GLY ALA SER ASP LYS PRO GLN SEQRES 14 A 614 ASN ASN PRO ASN PHE ASP PHE PHE ASN TYR CYS GLY ILE SEQRES 15 A 614 THR ARG PRO VAL LYS ILE TYR THR THR PRO GLU THR TYR SEQRES 16 A 614 ILE ASN ASP ILE THR VAL THR ALA ASP ILE ASP PHE THR SEQRES 17 A 614 LYS GLU GLU PRO SER ALA VAL LEU ASN TYR ASN VAL GLU SEQRES 18 A 614 ILE LYS GLY LYS ASP TYR ASN ASN ILE THR CYS LYS VAL SEQRES 19 A 614 GLU LEU PHE ASP GLU GLU GLY THR LYS LEU SER GLU THR SEQRES 20 A 614 GLU GLY SER GLU GLY THR PHE GLU ILE SER ASN VAL ARG SEQRES 21 A 614 LEU TRP GLN PRO LEU ASN ALA TYR LEU TYR LYS ILE LYS SEQRES 22 A 614 VAL THR ALA GLY GLN ASP VAL TYR THR LEU PRO TYR GLY SEQRES 23 A 614 VAL ARG SER VAL ARG VAL ASP GLY THR LYS PHE LEU ILE SEQRES 24 A 614 ASN GLU LYS PRO PHE TYR PHE LYS GLY TYR GLY LYS HIS SEQRES 25 A 614 GLU ASP THR PHE PRO ASN GLY ARG GLY ILE ASN LEU PRO SEQRES 26 A 614 MET ASN THR LYS ASP ILE SER ILE MET LYS TRP GLN HIS SEQRES 27 A 614 ALA ASN SER PHE ARG THR SER HIS TYR PRO TYR SER GLU SEQRES 28 A 614 GLU MET MET ARG LEU CYS ASP GLU GLU GLY ILE VAL VAL SEQRES 29 A 614 ILE ASP GLU THR THR ALA VAL GLY VAL ASN LEU GLN PHE SEQRES 30 A 614 GLY GLY GLY ALA ASN PHE GLY GLY GLU ARG ILE GLY THR SEQRES 31 A 614 PHE ASP LYS GLU HIS GLY VAL GLN THR GLN GLU HIS HIS SEQRES 32 A 614 LYS ASP VAL ILE ARG ASP LEU ILE SER ARG ASP LYS ASN SEQRES 33 A 614 HIS ALA CYS VAL VAL MET TRP SER ILE ALA ASN GLU PRO SEQRES 34 A 614 ASP SER ALA ALA GLU GLY ALA TYR ASP TYR PHE LYS PRO SEQRES 35 A 614 LEU TYR ASP LEU ALA ARG GLU LEU ASP PRO GLN LYS ARG SEQRES 36 A 614 PRO CYS THR LEU VAL SER VAL GLN GLY THR THR ALA ASP SEQRES 37 A 614 THR ASP CYS SER SER GLN LEU SER ASP VAL ILE CYS LEU SEQRES 38 A 614 ASN ARG TYR TYR GLY TRP TYR PHE GLY GLY PRO ASP LEU SEQRES 39 A 614 GLU VAL SER GLU THR GLY LEU ARG LYS GLU LEU SER ASP SEQRES 40 A 614 TRP GLY LYS LEU GLY LYS PRO VAL MET PHE THR GLU TYR SEQRES 41 A 614 GLY ALA ASP THR VAL SER GLY LEU HIS ASP THR THR SER SEQRES 42 A 614 VAL MET TYR THR GLU GLU TYR GLN VAL GLU TYR TYR GLU SEQRES 43 A 614 MET ASN ASN LYS VAL PHE ASP GLU PHE ASP PHE VAL VAL SEQRES 44 A 614 GLY GLU GLN ALA TRP ASN PHE ALA ASP PHE ALA THR SER SEQRES 45 A 614 GLN SER LEU LEU ARG VAL GLN GLY ASN LYS LYS GLY LEU SEQRES 46 A 614 PHE THR ARG ASP ARG LYS PRO LYS MET VAL ALA HIS TYR SEQRES 47 A 614 PHE ARG ASN ARG TRP SER ALA ILE PRO GLU PHE GLY TYR SEQRES 48 A 614 LYS THR LYS HET WOF A 701 65 HET WR8 A 702 46 HET GOL A 703 14 HET GOL A 704 14 HETNAM WOF 8-(4-BETA-D-GLUCOPYRANURONOSYLPIPERAZIN-1-YL)-5- HETNAM 2 WOF (METHYLAMINO)-1,2,3,4-TETRAHYDRO[1,2,3]TRIAZINO[4', HETNAM 3 WOF 5':4,5]THIENO[2,3-C]ISOQUINOLINE HETNAM WR8 N-METHYL-8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO[1,2, HETNAM 2 WR8 3]TRIAZINO[4',5':4,5]THIENO[2,3-C]ISOQUINOLIN-5-AMINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 WOF C23 H29 N7 O6 S FORMUL 3 WR8 C17 H21 N7 S FORMUL 4 GOL 2(C3 H8 O3) HELIX 1 AA1 GLY A 56 ASP A 61 1 6 HELIX 2 AA2 PRO A 75 LYS A 79 5 5 HELIX 3 AA3 ASN A 320 HIS A 335 1 16 HELIX 4 AA4 SER A 347 GLY A 358 1 12 HELIX 5 AA5 THR A 396 LYS A 412 1 17 HELIX 6 AA6 GLY A 432 ASP A 448 1 17 HELIX 7 AA7 CYS A 468 SER A 473 1 6 HELIX 8 AA8 ASP A 490 LYS A 507 1 18 HELIX 9 AA9 THR A 534 ASP A 550 1 17 HELIX 10 AB1 LYS A 590 ALA A 602 1 13 SHEET 1 AA1 4 LEU A 12 ASP A 14 0 SHEET 2 AA1 4 VAL A 183 THR A 188 -1 O ILE A 185 N SER A 13 SHEET 3 AA1 4 ARG A 82 CYS A 87 -1 N ARG A 82 O THR A 188 SHEET 4 AA1 4 PHE A 113 GLU A 116 -1 O VAL A 115 N LEU A 85 SHEET 1 AA2 6 ASP A 42 VAL A 46 0 SHEET 2 AA2 6 GLY A 17 LEU A 23 -1 N PHE A 21 O ASP A 42 SHEET 3 AA2 6 TRP A 65 ILE A 72 -1 O PHE A 67 N LYS A 22 SHEET 4 AA2 6 ASN A 126 ASN A 133 -1 O ILE A 130 N TYR A 68 SHEET 5 AA2 6 TYR A 93 LEU A 98 -1 N TYR A 97 O THR A 129 SHEET 6 AA2 6 LYS A 101 LYS A 107 -1 O ILE A 103 N ILE A 96 SHEET 1 AA3 2 GLY A 144 GLY A 145 0 SHEET 2 AA3 2 ASN A 168 PRO A 169 -1 O ASN A 168 N GLY A 145 SHEET 1 AA4 2 TYR A 192 ILE A 193 0 SHEET 2 AA4 2 ILE A 219 LYS A 220 -1 O LYS A 220 N TYR A 192 SHEET 1 AA5 3 THR A 197 ILE A 202 0 SHEET 2 AA5 3 ALA A 211 ASN A 216 -1 O VAL A 212 N ASP A 201 SHEET 3 AA5 3 THR A 250 ILE A 253 -1 O ILE A 253 N ALA A 211 SHEET 1 AA6 4 LYS A 240 GLU A 245 0 SHEET 2 AA6 4 CYS A 229 PHE A 234 -1 N VAL A 231 O THR A 244 SHEET 3 AA6 4 TYR A 267 ALA A 273 -1 O THR A 272 N LYS A 230 SHEET 4 AA6 4 VAL A 277 TYR A 282 -1 O TYR A 282 N TYR A 267 SHEET 1 AA7 3 VAL A 287 ASP A 290 0 SHEET 2 AA7 3 LYS A 293 ILE A 296 -1 O LEU A 295 N ARG A 288 SHEET 3 AA7 3 LYS A 299 PRO A 300 -1 O LYS A 299 N ILE A 296 SHEET 1 AA8 9 PHE A 303 GLY A 307 0 SHEET 2 AA8 9 SER A 338 ARG A 340 1 N SER A 338 O LYS A 304 SHEET 3 AA8 9 VAL A 360 GLU A 364 1 O ILE A 362 N PHE A 339 SHEET 4 AA8 9 VAL A 417 ASN A 424 1 O SER A 421 N ASP A 363 SHEET 5 AA8 9 CYS A 454 SER A 458 1 O THR A 455 N ILE A 422 SHEET 6 AA8 9 ILE A 476 ASN A 479 1 O CYS A 477 N SER A 458 SHEET 7 AA8 9 VAL A 512 GLU A 516 1 O THR A 515 N LEU A 478 SHEET 8 AA8 9 VAL A 555 ALA A 560 1 O GLY A 557 N PHE A 514 SHEET 9 AA8 9 PHE A 303 GLY A 307 1 N PHE A 303 O GLU A 558 CISPEP 1 VAL A 46 PRO A 47 0 14.13 CISPEP 2 LEU A 141 PRO A 142 0 9.79 CISPEP 3 PHE A 313 PRO A 314 0 -6.85 CISPEP 4 GLY A 488 PRO A 489 0 10.53 CISPEP 5 TRP A 561 ASN A 562 0 -3.72 CRYST1 179.938 179.938 132.792 90.00 90.00 120.00 P 64 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005557 0.003209 0.000000 0.00000 SCALE2 0.000000 0.006417 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007531 0.00000